pocketful logo
Themis Medicare Ltd logo

Themis Medicare Ltd

NSE: THEMISMED BSE: 530199

75.29

(0.04%)

Mon, 30 Mar 2026, 08:43 pm

Themis Medicare Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    642.12

  • Net Profit

    29.83

  • P/B

    3.65

  • Sector P/E

    31.93

  • P/E

    45.26

  • EV/EBITDA

    23.81

  • Debt/Equity (Industry)

    0.23

  • Interest Cover (Industry)

    9.71

  • ROCE (Industry)

    13

  • RONW (Industry)

    12.31

  • ROE

    8.36

  • ROCE

    11.09

  • Debt/Equity

    0.25

  • EPS (TTM)

    0

  • Dividend Yield

    0.72

  • Book Value

    37.68

  • Interest Cover

    4.95

Analysis

all

thumbs up icon

Pros

  • Dividends paid are thoroughly covered by earnings (15.4x coverage).
  • Themis Medicare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 2x debt.
thumbs up icon

Cons

  • Dividends per share have fallen over the past 10 years.
  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Themis Medicare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Themis Medicare's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Debt is not well covered by operating cash flow (0.4%, less than 20% of total debt).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters67.1167.1567.1567.1567.15
FII0.050.060.000.140.10
DII0.010.010.010.010.01
Public32.8332.7832.8332.7032.74
Government00000

Read More

Technical Analysis

RSI

30.70

MACD

-4.28

50 DMA

82.17

200 DMA

107.65

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic127.35106.5096.1585.6575.3064.8043.95
Fibonacci106.5098.5493.6185.6577.6972.7664.80
Camarilla91.5389.6287.7185.6583.8981.9880.07

Pivots Level: Classic

R3

+41.70

127.35

R2

+20.85

106.50

R1

+10.50

96.15

85.65
85.65
Pivot Point
LTP: 66.07

S1

-10.35

75.30

S2

-20.85

64.80

S3

-41.70

43.95

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    72.90

  • 20-EMA

    76.41

  • 30-EMA

    78.98

  • 50-EMA

    83.34

  • 100-EMA

    92.83

  • 200-EMA

    111.38

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
13 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
19 Aug 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 0.505 Sept 2025
04 Aug 2025dividendDividend - Re 0.50 Per Share05 Sept 2025
20 May 2025dividend₹0.50 Dividend /Share05 Sept 2025
12 Jun 2024dividendAnnual General Meeting/Dividend - Rs 0.50 Per Share15 Jul 2024
14 May 2024dividend₹0.50 Dividend /Share15 Jul 2024
14 May 2024agm
10 Sept 2023dividendFace Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share10 Oct 2023

Read More

Peer Comparison

Themis Medicare Ltd logo

Themis Medicare Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Read More

Themis Medicare Ltd About

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products especially in Formulation and API activity.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1969

Headquarters

CEO

Dinesh S Patel

Employees

Contact

Website icon

Website

http://www.themismedicare.com

Email icon

Email

sangameshwar.iyer@themismedicare.com; cfoassist@th

Phone icon

Phone

91-260-2421675

Location icon

Location

Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195

Read More

Themis Medicare Ltd Company History

YearHistory
2011
  • Themis Medicare introduced a 'calcium' preparation with fruity gummies for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare introduced a 'Multivitamin' for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare launched the brand LUMIXYL, entering the COSMETO-DERMATOLOGY segment.
2013
  • Themis Medicare Limited entered into a License and Supply Agreement with Novartis India Limited to supply Diclofenac topical gel.
  • Themis Medicare Ltd entered into a Supply & Distribution Agreement with Novartis India Ltd to supply Diclofenac Sodium 75mg per ml Injection.
2014
  • Themis invented Aquadol Spass 1ml Injection and commenced production, marketing, and sales.
2022
  • Inosine Pranobex, a unique Immunomodulator drug, received use approval from The Drug Controller General of India for the treatment of COVID-19.
2023
  • The Company has split its face value from Rs. 10/- to Rs. 1/-.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDBuy685949141.6109 Oct 2025
GRAVITON RESEARCH CAPITAL LLPSell659356141.6309 Oct 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDSell685949141.7209 Oct 2025
GRAVITON RESEARCH CAPITAL LLPBuy659356141.3209 Oct 2025
TEJAS TRADEFIN LLPBuy72009735.7602 Jun 2021
GAGANDEEP CREDIT CAPITAL PRIVATE LIMITEDSell11250060.2512 Mar 2013
ANUJ ANANTRAI SHETHBuy11250060.2512 Mar 2013
KISHORCHAND RATULSIDAS LAKDAWALASell235712181.526 Mar 2010
THEMIS DISTRIBUTORS PVT. LTD.Buy234612181.526 Mar 2010
KISHOR CHANDRA TULSIDAS LAKDAWALASell8997617504 Mar 2010

Read More

Themis Medicare Ltd News

Themis Medicare Postal Ballot Results Announced

Themis Medicare Limited announces successful completion of postal ballot with all four resolutions passed. The voting covered material related party transactions and convertible warrant issuance.

28 Mar 2026

companies

Themis Medicare Postal Ballot Results Announced

Themis Medicare Limited announces successful completion of postal ballot with all four resolutions passed. The voting covered material related party transactions and convertible warrant issuance.

28 Mar 2026

companies

Vividhmargi Investments Acquires Themis Medicare Shares

Vividhmargi Investments Private Limited acquired additional equity shares in Themis Medicare Limited through a scheme of amalgamation, increasing its shareholding from 15.77% to 26.52%.

28 Mar 2026

companies

Vividhmargi Investments Acquires Themis Medicare Shares

Vividhmargi Investments Private Limited acquired additional equity shares in Themis Medicare Limited through a scheme of amalgamation, increasing its shareholding from 15.77% to 26.52%.

28 Mar 2026

companies

Themis Medicare receives tax demand notice of ₹13.32 cr

Themis Medicare Limited received notice from Income Tax Department for outstanding tax demands totaling approximately ₹13.32 crore across assessment years 2017-18, 2018-19, and 2020-21.

27 Mar 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800